EN DE

Labixiaoxin Snacks Group (1262) Fair Value & Analysis

Consumer Defensive · HK · Market cap HK$577M

LS Labixiaoxin Snacks Group 1262 · HK
PriceHK$3.09
Fair ValueHK$0.8330
Upside-73.0%
Quality39/100
Watch Labixiaoxin Snacks Group for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 1.2% net margin
Low debt · negative free cash flow
Trails peers (4/13)
Narrow moat 25/100
Evidence: High Range HK$0.6205 – HK$1.09 Share as image

Fair value as of: Aug 13, 2026

From 16 valuation models · updated 2 days ago

Share price −1.0% over the past month.

Below-average quality, and screening another 73% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (HK$1.09). The favourable scenario is already priced in.
  • Weak quality (39/100) and above fair value at the same time, the margin of safety is missing on both counts.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

HK$5.50 HK$1.05 Fair Value HK$0.8330 Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range HK$1.05 – HK$5.50 · fair‑value band HK$0.6205 – HK$1.09 · the HK$3.09 price screens above the HK$0.8330 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Labixiaoxin Snacks Group (1262) currently trades at HK$3.09, while our model-based Fair Value estimate is HK$0.8330, implying the stock looks roughly 73.0% overvalued today. The Quality Score stands at 39/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Labixiaoxin Snacks Group generated revenue of HK$970M at a net margin of 1.2%. Revenue grew 21.7% year over year. It earns a return on equity of 5.4%. Net debt stands at HK$448M. Fundamentals as of Aug 13, 2026

Our scenario range runs from HK$0.6205 (bear case) to HK$1.09 (bull case); at HK$3.09, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 37% below its 52-week high and 102% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at -73%, 1262 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income HK$0.7000 HK$0.7000 HK$0.6500 76
ROIC Compounder HK$1.28 HK$1.48 HK$1.70 72
Gordon GGM HK$0.7900 HK$1.43 HK$1.97 70
All 16 models by family
Earnings-Based
Graham-Dodd HK$0.3400 HK$0.9900 HK$1.31 54
Lynch FV HK$0.2100 HK$0.3000 HK$0.3900 50
PEG = 1.0 HK$0.2100 HK$0.3000 HK$0.3900 46
EPV HK$1.24 HK$1.37 HK$1.47 59
Dividend Discount
Gordon GGM HK$0.7900 HK$1.43 HK$1.97 70
DDM Multi-Stage HK$0.7900 HK$1.21 HK$1.53 61
Multiples
P/E Multiple HK$0.7800 HK$1.04 HK$1.30 63
P/S Multiple HK$0.6300 HK$0.8400 HK$1.05 58
P/B Multiple HK$0.6300 HK$0.8400 HK$1.05 55
EV/EBIT HK$1.95 HK$2.49 HK$3.03 53
EV/EBITDA HK$2.79 HK$3.61 HK$4.43 54
EV/Revenue HK$1.48 HK$1.98 HK$2.48 43
Asset-Based
NCAV (Graham) HK$0.4700 HK$0.6300 HK$0.9500 50
Economic Profit
Residual Income HK$0.7000 HK$0.7000 HK$0.6500 76
ROIC Compounder HK$1.28 HK$1.48 HK$1.70 72
Growth Earnings
Growth-Adj P/E HK$0.6300 HK$0.9000 HK$1.18 68

Widest divergence: Dividend Discount (HK$1.21) versus Earnings-Based (HK$0.3000). Highest evidence: Residual Income (76).

Notify me when 1262 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) HK$970M
Revenue growth (YoY) +21.7%
Net margin 1.2%
Return on equity 5.4%
Free cash flow −HK$50.6M FY2025
P/E ratio 40.2 as of Jul 2, 2026
More key figures
Operating margin 4.7%
EPS (TTM) HK$0.0100
Net debt HK$448M FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 39/100

Of which business quality 38 · Market factors (momentum, volatility) 56

Profitability 42
Margins and returns on capital today
Quality Growth 74
Are margins and returns improving?
Cashflow 31
Earnings quality: real cash, not paper profit
Fin. Strength 18
Balance sheet, leverage, solvency risk
Investment 88
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 50
Price trend over the last 3–12 months (market factor)
52W Momentum 73
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Labixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China.

Full company description

Labixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China. It offers jelly snacks, such as fruit-flavored, canned fruit, yogurt, and mousse jellies; jelly beverages; lollipops, milk and gummy candies, and chocolates; fruit and vegetable beverages; and powdered milk tea, dried bean curd, and baked products under the Labixiaoxin, Sunshine City, Humor, and Xiangdoufang brands. The company was formerly known as China Lifestyle Food and Beverages Group Limited and changed its name to Labixiaoxin Snacks Group Limited in June 2012. Labixiaoxin Snacks Group Limited was founded in 2000 and is headquartered in Jinjiang, the People's Republic of China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Labixiaoxin Snacks Group reported revenue of HK$970M in FY2025 versus HK$648M in FY2021, a compound +10.6%/yr. Reported net income was HK$11.9M in FY2025.

Growth Quality 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
HK$970M
Latest YoY
+11.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+12.3%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.8%
Avg. growth/yr (23Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.9%
Revenue +10.6%/yr
FY21 HK$648M
FY22 HK$684M
FY23 HK$764M
FY24 HK$867M
FY25 HK$970M
Net income
FY21 −HK$65.2M
FY22 −HK$75.3M
FY23 −HK$105M
FY24 −HK$93.5M
FY25 HK$11.9M

1262 screens 73% overvalued. Compare with Nestlé India Limited →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Labixiaoxin Snacks Group Fair Value". https://www.fairvalue-calculator.com/stock/1262

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 39 · Bottom 25%
Fair Value upside −73% · Bottom 25%
Return on equity (TTM) 5% · Below median
Return on assets 2% · Below median
Net margin (TTM) 1% · Below median
Operating margin (TTM) 5% · Below median
Revenue growth 22% · Top 25%
Dividend yield (TTM) 4.2% · Above median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 40.2× · Pricier than 75% of peers
P/B 2.55× · Pricier than 75% of peers
P/S (TTM) 0.60× · Cheaper than median
EV/EBITDA 8.2× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 23
FUTURE 100 · sector 19
PAST 22 · sector 28
HEALTH 100 · sector 96
DIVIDEND 85 · sector 57

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,507 ₹362.37 -76%
Britannia Industries Limited BRITANNIA ₹5,646 ₹1,870 -67%
Tata Consumer Products Limited TATACONSUM ₹1,062 ₹327.27 -69%
PT Indofood CBP Sukses Makmur Tbk ICBP 7,550 IDR 12,864 IDR +70%
Samyang Foods Co 003230 1,219,000 KRW 1,010,543 KRW -17%
Patanjali Foods Limited PATANJALI ₹352.60 ₹144.77 -59%
Vietnam Dairy Products Joint Stock Company VNM 61,600 VND 52,858 VND -14%
PT Mayora Indah Tbk, MYOR 1,665 IDR 2,699 IDR +62%
PT Cisarua Mountain Dairy Tbk CMRY 4,630 IDR 4,350 IDR -6%
Nongshim Co 004370 389,500 KRW 530,619 KRW +36%

Compare Labixiaoxin Snacks Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Labixiaoxin Snacks Group (1262) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of HK$0.8330 versus a price of HK$3.09, about −73% (overvalued).
What is the fair value of 1262?
Our model-based fair value for Labixiaoxin Snacks Group is HK$0.8330 (as of Aug 13, 2026), built from audited fundamentals. The current price is HK$3.09.
What is the quality score of 1262?
Labixiaoxin Snacks Group has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Labixiaoxin Snacks Group (1262)?
Labixiaoxin Snacks Group reported trailing-twelve-month revenue of about HK$970M (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 1262?
The net profit margin of Labixiaoxin Snacks Group is about 1.2%, meaning it keeps roughly 1.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Labixiaoxin Snacks Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.